NDMA: What Is it and Why Should I Be Concerned?
The drug Valsartan was recently recalled due to the contamination of n-nitrosodimethylamine (NDMA), a probable human carcinogen. Many individuals don’t know what NDMA is or how it can impact their health and lifestyle. Here we’ll explore what it is and why the recall was necessary.
What Is NDMA?
According to the Environmental Protection Agency (EPA), NDMA is a semi-volatile organic chemical that can form naturally and unintentionally through industrial processes. NDMA can form as a byproduct of the chlorination of wastewater and drinking water. NDMA was found in Valsartan tablets produced by three different facilities: Zhejiang Huahai Pharmaceuticals in China, Hetero Labs Limited in India, and Zhejiang Tianyu in China.
What Are the Effects?
NDMA can contaminate drinking water and humans often get NDMA exposure from consuming food or drink that was contaminated with NDMA. Exposure to NDMA can cause liver, kidney, stomach, intestinal, and colorectal cancer. Even small amounts of exposure can lead to liver damage.
Classified as a Carcinogen
The EPA classifies NDMA as a B2 carcinogen, meaning it is a probable human carcinogen. B2 carcinogens do not have enough human data but have a sufficient amount of animal data to conclude that it’s a potential carcinogen. Many animal studies were done to test NDMA, and they found that various species, including rats and mice, developed tumors in the liver, respiratory tract, kidney, and blood vessels after exposure to NDMA. The U.S. Department of Health and Human Services believes that NDMA is “reasonably anticipated to be a human carcinogen.”
If you or a loved one contracted cancer after taking Valsartan, contact the dangerous drug attorneys at GoldenbergLaw. We are committed to promoting safety through accountability.